Harness attends HD Clinical Research Congress

Over the weekend our COO, Madeleine Wakeling, attended the Huntington Study Group’s inaugural HD Clinical Research Congress in Nashville, meeting leading researchers, clinicians, and industry partners in Huntington's Disease (HD) research.

It was an invaluable opportunity to connect with the HD community and share insights on innovative approaches being developed to change the course of this disease. During the conference, Madeleine shared a poster on Harness’ FAN1 upregulation approach and its potential to delay the onset of HD.

We remain committed to sharing our findings as we progress with HD research and look forward to next year’s event!